Birinyi Associates Inc Moderna, Inc. Transaction History

Birinyi Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 05, 2022	SELL	$126.46 - $235.05 $284,535 - $528,862	-2,250 Closed	0 $0
Q4 2021 Jan 26, 2022	SELL	$225.82 - $368.51 $541,968 - $884,424	-2,400 Reduced 51.61%	2,250 $571,000
Q3 2021 Oct 18, 2021	BUY	$221.9 - $484.47 $477,085 - $1.04 Million	2,150 Added 86.0%	4,650 $1.79 Million
Q2 2021 Aug 05, 2021	SELL	$129.91 - $234.98 $142,901 - $258,478	-1,100 Reduced 30.56%	2,500 $587,000
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $393,048 - $669,528	3,600 New	3,600 $471,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Birinyi Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Birinyi Associates Inc with notifications on news.